NIVF
NIVF
NASDAQ · Health Care

Newgenivf Group Ltd-A

$1.00
+0.00 (+0.00%)
As of Feb 8, 2:35 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 401.7K 362.7K 344.3K
Net Income 41.8K 46.7K 41.5K
EPS
Profit Margin 10.4% 12.9% 12.1%
Rev Growth +17.6% -6.2% -6.6%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 153.4K 184.7K 169.1K
Total Equity 435.1K 422.0K 475.1K
D/E Ratio 0.35 0.44 0.36
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 62.8K 66.4K 61.5K
Free Cash Flow 54.6K 52.4K 38.3K